Moderna Tunes Vaccine Platform to Next Potential Viral Threat: Monkeypox

May 24, 2022

(Fierce Biotech) – As cases of monkeypox continue to creep up worldwide, Moderna is turning its vaccine platform towards finding a jab to defend against the disease. The Cambridge, Massachusetts biopharma, responsible for one of the most effective COVID-19 vaccines on the market, announced plans to explore potential vaccines for monkeybox at a “preclinical level,” according to a Monday announcement. (Read More)